<DOC>
	<DOC>NCT01115465</DOC>
	<brief_summary>The ROSE Registry will determine the long-term safety and effectiveness of Macroplastique in the treatment of female stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD).</brief_summary>
	<brief_title>Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Stress</mesh_term>
	<criteria>Subject has signed written informed consent Subject is a female at least 18 years of age Subject has been diagnosed with SUI primarily due to intrinsic sphincter deficiency (ISD) Subject understands all study requirements including five year followup schedule Subject is psychologically stable and suitable for intervention as determined by the Investigator Subject has an acute urogenital tract inflammation or infection Subject is pregnant or intends to become pregnant within one year Subject has had a sling placement within 12 weeks Subject has had a bulking agent treatment within 12 weeks Subject has a bladder neck or urethral stricture, gross uterovaginal prolapse, untreated detrusor instability or hyperreflexia, neuropathic bladder, or overflow incontinence</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Stress Urinary Incontinence</keyword>
	<keyword>silicone elastomer</keyword>
</DOC>